Also trades as: IBO.V (TSXV) · $vol 0M
IBOGF OTC
Universal Ibogaine Inc.
1W: -99.0%
1M: -99.5%
3M: -99.6%
YTD: -98.0%
1Y: -98.8%
3Y: -99.1%
$0.00
-0.00 (-50.00%)
Weekly Expected Move ±623575.0%
$-1
$-1
$0
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.00001-0.35
Volume31,000
Avg Volume286,351
Beta4.38
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEONicholas Peter Karos
Employees7
SectorHealthcare
IndustryBiotechnology
IPO Date2022-03-01
Websiteuniversalibogaine.com
400 3rd Avenue SW
Calgary, AB T2P 3P2
CA
Calgary, AB T2P 3P2
CA
855-426-4246
About Universal Ibogaine Inc.
Universal Ibogaine Inc., a life sciences enterprise, focuses on developing, acquiring, and operating addiction treatment centers across Canada. The company is additionally preparing to launch clinical trials aimed at researching ibogaine's potential therapeutic applications for addiction. Its principal corporate offices are based in Calgary, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found